Current status of clinical studies of recombinant factor VIII (recombinate) in patients with hemophilia A. Recombinate Study Group.
Bray
G L
GL
Department of Hematology-Oncology, Children's Hospital, Washington, DC 20010.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005169:Factor VIII / Q000276:immunology / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007518:Isoantibodies / Q000097:blood; D011994:Recombinant Proteins / Q000276:immunology / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII